Number of new molecular entities launched in the U.S. from 2003 to 2015

Number of new drugs launched in the U.S. 2003-2015 This statistic shows the number of new molecular entities launched in the United States from 2003 to 2015. In 2003, a total of 24 new medicines were launched in the United States, six of them were orphan drugs.
Show more
Loading statistic...
New MechanismOrphanExisting Mechanism
20031365
20041253
20051146
20061099
2007657
2008767
20098718
2010989
2011111210
20121288
201381711
201472018
2015141514
New MechanismOrphanExisting Mechanism
20031365
20041253
20051146
20061099
2007657
2008767
20098718
2010989
2011111210
20121288
201381711
201472018
2015141514
Download Settings Share
Chart type
Datalabels
Share on Social Media
HTML code to embed chart as PNG (FAQ)
Download started
Please be patient - this may take a moment
Description Source More information
This statistic shows the number of new molecular entities launched in the United States from 2003 to 2015. In 2003, a total of 24 new medicines were launched in the United States, six of them were orphan drugs.
Show more
Release date
April 2016
Region
United States
Survey time period
2003 to 2015
Supplementary notes
New Molecular Entity (NME): A novel molecular or biologic entity or combination where at least one element is novel.
This statistic was assembled from several IMS Health reports.
NME launches in the U.S. by year of launch, regardless of timing of FDA approval.
New mechanism: First product with a new mechanism of action for its FDA approved indication.
Orphan: Drugs with one or more orphan indications approved by FDA at launch.
Existing mechanism: Subsequent products with an existing mechanism of action for an indication.

More information

Statista Accounts: Access All Statistics. Starting from $588 / Year

Statistics on "U.S. pharmaceutical industry"

  • Contribution to global pharma
The most important statistics
  • Overview
  • Companies
  • Research and development
The most important statistics
  • Generics
The most important statistics
  • Outlook
  • The consumer's view
The most important statistics

Related Studies: Available to Download in PDF or PPTX Format

U.S. pharmaceutical industry

All Information
in one Presentation

U.S. pharmaceutical industry

Everything On "U.S. pharmaceutical industry" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista for Your Company: The Research and Analysis Tool

  • Product Film
  • Statistics
  • Downloads

Our Premium Statistics - facts for your business

Currently, Statista provides more than 1 million statistics.
93 percent (all Premium content) are exclusively accessible via our professional accounts.

Unlimited access

As a Statista Premium customer, you receive unlimited access to all statistics at all times. Including downloads of data in the most common formats (XLS, PDF & PNG). Create relevant and significant statistics in no time.

You are in good company

Further Content: Statistics, Studies, and Topic Pages

Our Business Solutions: Save Time and Money

only

$588*

per year
Your advantages
  • Full access to all our statistics
  • Download as XLS, PDF & PNG
  • Relevant data: complete source information
All functions of our platform illustrated face-to-face
  • Learn how Statista supports your company
  • Extensive tour across the whole portal
  • Personal guidance by our support team
The knowledge database for your company
  • All functions of the Premium Account
  • Access to dossiers, forecasts and studies
  • Access to our international database
  • Publishing rights and other exclusive functions

Statistics on the topic

Topics

About Statista

Learn more about how Statista can support your business.

Request webinar